Loading
Latest filing published 07 May 2026 for 채비. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
이동철 is a declared insider at 2 companies (chief executive); the most frequent names are 명인제약 and 채비. In total, 2 filings cover trades dated from 6 April 2026 to 7 May 2026.
No open-market sale appears; the market trades are 1 purchase. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 7 May 2026, reports an open-market purchase in 채비. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.